• Daniel Monsivais, Miriam Morales, Arthur Day, Dong Kim, Brian Hoh, and Spiros Blackburn.
• Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA. Electronic address: Daniel.R.Monsivais@uth.tmc.edu.
• World Neurosurg. 2018 Dec 19.

BackgroundCost-effectiveness analyses for the treatment of aneurysmal subarachnoid hemorrhage are necessary to determine health policy, treatment guidelines, and screening protocols for cerebral aneurysms. To perform these modeling studies, detailed cost data are necessary and are currently lacking.ObjectiveThe goal of this study was to determine detailed inpatient cost of aneurysmal subarachnoid hemorrhage.MethodsA retrospective review of our ruptured subarachnoid hemorrhage database was performed to identify consecutive patients between January 2013 and December 2015. Patients were searched by International Classification of Disease 9 diagnosis and procedure codes. Patient demographics and clinical characteristics were acquired. The cost breakdown was compiled into a comprehensive itemized list encompassing all aspects of hospitalization. A mean cost based on resource used per patient was obtained.ResultsThere were 269 patients treated, 209 were coiled and 60 were clipped. Mean age in the clipping group was 49 years and 55 years in the coil group (P = 0.006). Other patient demographics and clinical characteristics were found to be statistically similar for both groups. Total cost per patient for treatment and hospital stay was $74,192 for clipping and $85,553 for coiling (P = 0.06). Cost amplified with increasing Hunt and Hess grade in both clipping and coiling groups.ConclusionsThe detailed cost information reported in this article can be used to help establish appropriate, standardized costs nationally by improving transparency. It can also help provide critical information necessary to develop cost-effective treatment algorithms and screening protocols.Copyright © 2018 Elsevier Inc. All rights reserved.

6 keywords...

hide…